Express News | Cantor Fitzgerald Reiterates Overweight on Sanara MedTech, Maintains $44 Price Target
Sanara MedTech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 40.04% Cantor Fitzgerald → $44 Reiterates Overweight → Overweight 03/27/2024 40.04% Cantor Fitz
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Sanara MedTech (SMTI)
Q1 2024 Sanara Medtech Inc Earnings Call
Sanara MedTech Inc (SMTI) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ...
Earnings Call Summary | Sanara MedTech(SMTI.US) Q1 2024 Earnings Conference
The following is a summary of the Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript:Financial Performance:Sanara MedTech experienced a record Q1 2024 with $18.5 million in revenue, fueled by
Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript
Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript
Sanara MedTech EPS of -$0.21, Revenue of $18.5M Misses by $0.7M
Sanara MedTech EPS of -$0.21 Misses by $0.14, Revenue of $18.5M In-line
Sanara MedTech | 10-Q: Quarterly report
Express News | Sanara Medtech - on May 12, Appointed Ronald T. Nixon as CEO to Serve in Such Position Until His Successor Is Elected and Qualified
Express News | Sanara Medtech Inc - on May 10, Zachary B. Fleming Delivered Notice to Board That He Is Resigning From His Position as CEO
Sanara MedTech 1Q Loss/Shr $0.21 >SMTI
Sanara MedTech 1Q Loss/Shr $0.21 >SMTI
Express News | Sanara Medtech Inc. Announces First Quarter 2024 Results
Express News | Sanara Medtech Q1 Revenue USD 18.5 Million
Express News | Sanara Medtech Q1 Net Income USD -1.8 Million
Insiders Own 30% of Sanara MedTech Inc. (NASDAQ:SMTI) Shares but Individual Investors Control 32% of the Company
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ:SMTI), a medical technology company focused
Express News | Sanara MedTech Entered Into $55M Non-Dilutive Term Loan Agreement With CRG Servicing To Support Growth Initiatives In 2024 And 2025
Express News | Sanara Medtech Inc. Announces $55 Million Debt Facility
No Data